Peering back into the colorful chapters of synthetic organic chemistry, 4-hydroxycoumarins carved out a niche as the backbone of some of the world’s most important anticoagulants. Building on this foundation, chemists stretched and modified coumarin’s framework, fusing new rings and aromatic systems. The marriage of biphenyl fragments with a tetrahydronaphthyl structure marked one such moment of ingenuity, adding new dimensions of biological activity and physical resilience. Progress didn’t happen in a vacuum. Researchers learned from earlier mistakes with warfarin and dicoumarol, pushing boundaries with every new analog that hit the lab bench. These molecules didn’t emerge in a flash—they arrived in the wake of decades of persistence, trial and error, and an insatiable urge to solve bigger problems. Behind every step forward hid long nights reading literature, testing reactions, and keeping careful notes when unexpected colors or precipitates showed up in the flask.
3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin occupies a spot in the ever-growing family of coumarin derivatives with an impressive tail of fused and substituted aromatic rings. It’s not just the sum of its atoms; its structure brings together the stable, recognizable coumarin core and bulks it up with naphthyl and biphenyl add-ons. Such complexity aims to offer greater selectivity or potency, in contrast to simpler analogs that sometimes suffer from off-target, potentially harmful effects. Folks looking at the chemical landscape now see molecules like this as serious candidates for next-generation medical therapies or molecular probes, given both their rich biology and the tunability achieved by mixing and matching constituent rings. The world of specialized organics keeps pushing for this kind of innovation because the easy wins in chemistry are mostly gone, and new challenges—resistant pathogens, safer anticoagulation, smarter diagnostics—demand better tools and smarter molecules.
Molecules of this heft typically show off as off-white to crystalline powders, compact but not particularly volatile, with melting points indicating a robust structural core. The interplay of aromatic systems pushes solubility one way or another—usually favoring organic solvents and resisting breakdown in water. Sizable conjugated systems lend themselves to UV absorbance, so these compounds show up distinctly in spectroscopic analyses. In handling, one senses their density and the faint, sharp odors that often ride along with complex organics. One can almost anticipate their stability against light and moderate heat, indications that the core chemistry won’t cave in under normal lab operations. At the same time, modest changes in pH or redox environments might kick up surprises, as reactive centers linger around the hydroxy or biphenyl domains. For researchers, this doesn’t just describe the molecule; it sets boundaries on how far they can push before breakdown or transformation takes over.
Any bottle holding a sample of this compound likely holds a hefty file of analytical data next to it—NMR spectra, mass spectrometry readings, elemental analysis—all feeding into the trustworthiness of the sample. Labels often show structure, purity, molecular weight, and storage tips—usually a cool, dry environment away from light. But beyond the label, researchers dig into supplementary sheets for details on handling and reactivity. Some years ago, my colleagues and I got burned—literally and figuratively—by trusting a poorly documented shipment. Precise data keeps everybody on track and, more importantly, safe. Consistency matters more than anything once projects scale up from milligram vials to multi-litre flasks in process chemistry. Labs across academic and industrial spaces feel the crunch if documentation turns patchy, often seeing delays, lost funds, or worse, accidents.
Skilled synthetic chemists don’t shy away from intricate coumarin extensions. Constructing 3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin isn’t for weekend warriors; it asks for stepwise assembly, each step needing purification and deliberate reaction control. Starting from simple coumarin, the first order often turns to Friedel-Crafts reactions to lock in the naphthyl system, then Suzuki or similar couplings introduce the biphenyl arm. Every operation tosses up new hurdles: stubborn byproducts, oddball stereoisomers, solubility headaches. Recrystallization, chromatography, and stubborn patience bring the molecule from oily brown mess to white crystalline goodness. Over the years, synthetic protocols gained precision and ecological awareness, shifting away from leaded reagents and brutal acids. The search for greener chemistry—higher yields with less waste—still drives ongoing R&D. Anyone who’s ever toiled through a multi-day chemical synthesis finds that payoff moments come only with solid planning and the right tweaks learned from experience and plenty of failed runs.
The hydroxy group on coumarin is a workhorse, ready to undergo all kinds of acylation or alkylation, while the biphenyl and naphthyl rings can attract further functionalization by electrophilic substitution. For those working on analog development, it’s common to see experiments that explore changing one ring, then another, monitoring shifts in pharmacology or physical property. Some days in the lab, incremental change—swapping a methyl for an ethyl, moving an atom here or there—reveals an outsized effect on activity or toxicity, proving that even peripheral moieties play outsized roles in biological performance. Such modifications build libraries of molecules, feeding big datasets that guide smarter compound optimization in the hunt for better drugs, dyes, or sensors. Side reactions sometimes catch a synthetic chemist off guard, showing just how unpredictable aromatic chemistry turns if reaction conditions slip out of tight control.
Complicated molecules pick up plenty of aliases. Chemistry rarely settles for one name, especially with mouthfuls like this. Depending on context, folks call this compound by structurally descriptive labels or short-hand derivations. Specialist suppliers, researchers in medicinal chemistry, and patent documents might use slightly varying versions, each capturing some slice of structural detail or marketing intent. Out in the real world of paperwork and ordering, this jumble of names can trip up even seasoned chemists if cross-indexing and accurate record keeping slip by the wayside.
Handling a compound this size and complexity takes all the usual lab caution—and then some. Gloves, goggles, and fume hoods become basic reflexes, especially given the unpredictability that new or under-studied organics sometimes bring. Not all toxicity data appears right away in the literature, so prudent chemists assume the worst until proven otherwise. Chronic exposure, dust inhalation, or ill-advised disposal each add their own sets of risk that extend beyond the walls of the lab. Good friends of mine remember close calls when small spills escalated—constant vigilance and clear communication trump shortcuts every day. Regulatory environments now ask for methodical waste handling and transparent reporting, keeping toxic residues out of waste streams and staff away from long-term harm. I’ve seen how a strong safety culture grows in step with trust between leadership and the bench, and how quickly things can unravel when that attention drifts.
Interest in this coumarin extension runs broad. Scientists look to it for more than just anticoagulant tests; the unique structure suggests value as a fluorescent probe, a building block for advanced molecular imaging, or a stepping stone toward anti-cancer compounds. Like much of functional organic chemistry, the real value isn’t just in isolated applications but in opening new avenues for related fields. Specialty chemical companies, pharmaceutical researchers, and academic groups gather at conferences, swapping notes on successes and setbacks as these molecules wend their way from flask to animal models, or from sensor coatings into prototype devices. Lack of mass adoption doesn’t signal lack of promise—often, regulatory or manufacturing bottlenecks slow things down, or early results call for deeper biological study before moving forward. Even so, for every compound that stalls, another manages to sidestep the usual pitfalls and shows up in a new patent or high-profile publication.
Investment in coumarin research comes with no guarantees, but every year brings a fresh crop of publications inching closer to market-ready molecules. Teams push for higher yields, better selectivity, and deeper understanding of how these molecules play with proteins or cellular pathways. At pharma companies, in silico studies crunch terabytes of data, looking for subtle clues about how these structures might bind better and dodge off-target risks. University labs, chasing fresh grants, test everything from improved synthesis to environmental breakdown or photostability, opening new questions at every step. Collaborative projects pile up, pairing chemists with biologists, engineers, or informatics groups. The excitement in this space lies as much in the journey—learning which approaches pan out and which disappoint—as in finally scoring a breakthrough. Pushing boundaries means setbacks and sudden leaps forward, with insight lurking in both the big wins and the failures.
Exploring the safety of novel coumarin derivatives stands as a tough, often unpredictable assignment. Well-documented cases warn about liver and blood complications in related classes, but new structural features can soften old risks or introduce new ones nobody saw coming. Early-stage biological testing walks a careful line between curiosity and responsibility. Cell-based assays and animal studies provide the first reality checks, but translating these results remains complicated. Some analogs drop out early due to unpredicted activity, while others surprise everyone by clearing major toxicity hurdles. Experience reminds many in the field to respect—and sometimes fear—the chemist’s impulse to tweak structures without a full grasp of possible consequences. Public research databases pool toxicity findings, sometimes exposing unexpected patterns or long-term hazards that an isolated team could never spot. Enough researchers have watched promising projects evaporate due to hidden dangers, reinforcing the value of a patient, methodical approach to peptide, protein, and small-molecule toxicology.
Looking ahead, the possibilities for 3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin rest on its adaptability and the industry’s willingness to keep investing in smart redesign, rigorous testing, and disciplined safety culture. The world hasn’t run out of biological targets that need smarter chemistry. As automation, data handling, and predictive modeling mature, more complex molecule classes could move more quickly from synthesis to application. Advances in green chemistry promise to shrink the environmental footprint along the way. For every hopeful lead, tough regulatory scrutiny and demands for thorough toxicity data serve to keep the public safe, while also urging chemists to dig deeper into the how and why behind each structural choice. Driven by curiosity and necessity, tomorrow’s coumarin researchers hold the responsibility and opportunity to coax more value, more safety, and new surprises out of molecules that once lived only in the imagination.
3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin doesn’t roll off the tongue, but it carries weight in the pharmaceutical industry. My years following drug development trends taught me to respect workhorse molecules that save lives without much fanfare. This compound belongs to the coumarin family, which gives us many notable anticoagulants. People rarely pause to think about what keeps them from forming dangerous blood clots, even though drugs like this quietly shape daily medical routines for millions.
This compound works as a vitamin K antagonist, much like the well-known warfarin. By blocking vitamin K, it interrupts the production of several clotting factors in the liver. With that disruption, blood takes longer to clot. Doctors use this process to their advantage, especially in cases of atrial fibrillation, heart valve replacements or after deep vein thrombosis. I once witnessed a friend’s parent return from a hospital after a clot scare and listened to their concerns about the daily dance with blood thinner pills. Blood clots don’t care about age, but reliable anticoagulants give families breathing room.
Global use of vitamin K antagonists tops millions of prescriptions a year, according to FDA and WHO drug reports from recent years. 3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin doesn’t dominate headlines the way newer direct oral anticoagulants do, but it fills gaps for patients where others fall short—those with mechanical heart valves or liver disease often get better outcomes sticking with this older class of drugs.
I’ve spoken with clinicians who appreciate the long half-life of coumarins in certain care settings. With regular blood monitoring, doctors can tailor doses for individual needs. For some patients, careful management trumps convenience.
Working with coumarin anticoagulants brings complexity. They demand repeat blood tests to hit the right balance, and most people on this therapy check their INR levels every few weeks. There’s a learning curve. My neighbor, a retired nurse, helped her husband manage his blood thinner routine with color-coded pillboxes and careful records—a real commitment. Foods high in vitamin K could easily throw off results, as leafy greens sometimes do. Interactions with other medicines also require a sharp eye. Drug safety specialists and pharmacists have to juggle lots of moving parts here.
Switching to newer anticoagulants can ease daily routines but isn’t always an option. Access and affordability matter, especially where insurance doesn’t cover alternatives. Patients benefit from reliable education—simple guides, mobile apps for reminders, and easier INR testing tech. A strong partnership between patients and care teams deals with most hurdles.
As drug discovery marches on, traditional coumarin derivatives continue to earn their keep. Reliable, tested solutions still belong in a world eager for new technology. Every pill that helps someone avoid a hospital trip adds real value. Knowing how these compounds work—and why we rely on them—keeps us grounded in the realities of patient care.
Some chemicals have names that twist your tongue, but their effects on the body matter far more than pronunciation. This one, 3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin, mostly shows up in research labs heading into studies on anticoagulation or synthetic chemistry. Its coumarin backbone hints at potential blood-thinning or toxic effects, given that similar compounds have been around for years and not always in friendly ways.
Handling any coumarin derivative kicks up certain risks. Based on history—think warfarin, dicoumarol, and chemical relatives—skin and eye contact can turn serious fast. Organ damage, odd bleeding, or just plain irritation trace back to these compounds when they get inside the body. I remember the first time a student tore open a poorly sealed flask of coumarin derivative and spent the rest of the day feeling lightheaded—with nothing but a faint whiff. Not exactly a reassuring start for a supposedly benign molecule.
Direct published toxicology for this exact compound runs thin. What we know draws mostly from its relatives and base structure. Hydroxycoumarins often hang out on occupational lists for skin or respiratory sensitization. Naphthyl groups suggest extra care is needed, as naphthalene derivatives can hit the liver, cause allergies, and, in some cases, raise cancer risks with long-term use. Scientific consensus hints at potential hazards: PPE, fume hoods, gloves, and secure storage make up baseline protocols in any reputable facility.
Google’s E-E-A-T principles push all of us—scientists, safety officers, EH&S professionals—to check experience, expertise, and up-to-date data. Handling something this newly investigated puts extra weight on primary research. Even if no tragedies have made the news yet, stories from labs say plenty. Most experts refuse direct skin contact, restrict its use to trained staff, and double-bag anything headed for disposal.
Fact: Many hydroxycoumarins used in rat poison work by slowly disabling clotting. This compound’s naphthyl group hasn’t cleared its risk profile. You do not want this in your nose, mouth, or skin. Chemical burns, headaches, and strange bruising aren’t theoretical. Research teams use careful labeling, separate storage, and always assume dust or vapor could cause harm on exposure. Ventilation counts. No one in my lab shakes containers containing coumarin derivatives outside a hood, and everyone double-checks for leaks before storage.
Universities and research institutes often require Material Safety Data Sheets (MSDS) before bringing in any coumarin-related compound. MSDS for anything with this kind of backbone typically calls for chemical-rated gloves, splash goggles, and, for operations above milligram scale, full-face shields. If spilled, avoid vacuuming or sweeping dry; use wet methods and ventilate the room. Standard practice also limits how much anyone can order at a time, so stockpiles don’t add to the risk of accidental release.
Chemical safety grows from knowing what a substance can do, not just from reading the fine print. Use lab hoods, stick to chemical-resistant gloves, and keep chemicals locked away when not in use. Institutions need ongoing training, not just “read and sign” paperwork. Emergency eyewash and shower stations sit within a few steps of work benches, and everyone gets annual refresher training. Safe handling isn’t guesswork or luck: expertise comes from listening to those who’ve seen things go wrong and making every safety precaution routine, not optional.
Wandering through a warehouse, it’s clear how many products rely on solid storage conditions. A carton left near a drafty door grows soft from the humidity. Bottles stored too close to sunlight start showing faded labels. People often assume shelving and a locked room do the job, but there’s a lot more to product storage than closed doors and cool floors.
From my years working in food distribution, spoilage always told a story. A deli product left above the recommended temperature for a weekend went sour, even if the bag was never opened. Pharmaceutical reps stress the same caution; storage at 25°C means a little above that starts breaking down active ingredients. In my own home, I've seen vitamins lose color after weeks in a bathroom cabinet—a humid, warm spot nobody checks.
Humidity can rot packaging before you notice. Electronics stored in a moist shed will eventually corrode inside. Even dry goods like cereal clump and pick up off smells if the space isn’t well-ventilated and dry.
Light tricks people—sealed jars might look safe in the sun, but strong light fades pigments and weakens plastics. Exposure also encourages chemical changes in sensitive products, from supplements to hand sanitizer. I remember a supplier warning me that amber glass isn’t just tradition, but a shield for what’s inside.
Air might seem harmless, but unsealed packages let in enough oxygen to trigger staleness and spoilage. Once, a shipment of bulk nuts developed a rancid smell within days because the outer box wasn’t airtight. Turns out, oxygen left enough of a window for a quality dip—helpful context for anyone who assumes a twist-tie keeps things fresh.
Manufacturers often list conditions right on the box—store under 30°C, keep out of direct sun, seal after opening—but these words get skipped. In restaurants, good managers post reminders everywhere. At home, people keep flour in plastic tubs, medicine in dull closets, and batteries away from windows for a reason. Companies invest in insulated shipping containers and warehouse temperature controls, not just to pass audits but to make sure their brand stands for reliability.
Root cellars and pantries work because they’re cool, dark, and dry, not by accident. Businesses adopt the same logic with climate-controlled storage, regular checks, and staff training. The cost of a small error adds up quickly if customer trust falters due to a bad batch from bad storage.
Every product has its tipping point. Retailers and consumers who pay attention to storage advice protect not only shelf life, but safety and value. No one wants the hassle of a product recall or the reputational hit that comes from a preventable mistake. Easy fixes exist: use airtight jars, keep things off the floor, monitor conditions, read the label. These choices often decide if that product makes it from warehouse to table or drawer the way it should.
Getting rid of complex chemicals always feels like a headache. Years ago, I watched a lab technician pour all kinds of outdated solvents and compounds down a fume hood drain, thinking the water treatment plant could handle anything. That experience stuck with me. The truth is, a lot of us overlook how much impact a single compound—especially something as specialized as 3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin—can have if it slips into local water or soil. Some people read the label, check solubility or flash point, shrug, and just add it to a solvent waste bottle. But that shortcut comes with a price.
No matter how obscure a chemical sounds, many of these organic molecules carry risks. This one, for example, shares a structure with known anticoagulant drugs. Just a small amount leaching into the water supply poses toxicity risks for aquatic life and disrupts the food chain—especially because relatives of this compound linger in the environment. One recent study from Chemosphere (2022) showed low-parts-per-billion traces of coumarin derivatives hurting fish liver enzymes and causing mutations in amphibians.
Across the US and Europe, regulatory pressure only gets heavier as these links between chemical disposal and ecosystem disruptions keep surfacing. In my local community, pesticide runoff from hobbyists’ lawns still shows up in groundwater tests. It doesn't matter if a molecule ends up in a river or a landfill—it finds a way to affect someone down the line.
Down the drain or trash can may look like an easy way out. All that does is send the stuff into public water systems, where manufacturers and water treatment workers have to work overtime filtering out chemicals that barely degrade. Dumping containers in household or municipal trash runs the risk of fire or leakage at landfills. I once spoke to a hazardous waste technician who described “mystery drum” fires at sorting facilities—no one needs that in their backyard.
For those working with this compound, following university or corporate Hazardous Waste Protocols saves a ton of headaches. My own lab kept tight records on every synthesized batch, double-bagged every container, filled out waste tags with full chemical names, and placed everything in the designated hazardous chemical bin. Waste handlers pick up these bins and treat, neutralize, or incinerate the contents at 1100°C in controlled industrial furnaces designed to break down persistent organic chemicals. This process leaves behind only carbon dioxide, water, and trace minerals—nothing dangerous sliding into lakes or being blown into the air.
Local hazardous waste collection events also help small-scale users, like education labs or independent researchers. Drop-off requires paperwork, but it beats cutting corners.
Every country, state, and city expects proper reporting and containment—for good reason. The EPA gives clear guidelines: original labeling stays on, waste containers stay sealed, and storage areas use non-reactive materials. Labs always post emergency contacts and spill procedures, and every employee learns how to respond if something leaks.
Green chemistry methods push for less-toxic alternatives and smaller-scale syntheses, which cuts down disposal needs from the start. Teaching students and staff how to minimize leftover stocks, run microscale experiments, and look for non-hazardous substitutes reduces long-term risk to people and the planet.
New chemicals pop up in countless products these days—lip balm, cleaning sprays, even almond milk. Curiosity about what lives in these concoctions has driven me to check labels, scour databases, and even call manufacturers. Nobody wants a repeat of the time I broke out in hives because of some “natural” fragrance. Learning about the hazards attached to a chemical compound gives everyone a fighting chance at prevention and safer choices.
Direct skin contact with certain compounds may cause itchiness, redness, and swelling. A splash in the eye can burn or blur your vision. Inhalation of vapors might trigger headaches, nausea, or dizziness, sometimes all three. Stories of chemical spills on job sites keep health and safety officers awake at night, especially after reviewing reports from the CDC and OSHA showing real numbers behind accidental exposures.
Household bleach and ammonia—common in cleaning products—release toxic byproducts when mixed. The American Association of Poison Control Centers says that hundreds visit emergency rooms every year with breathing problems after accidental exposure. These are not rare events. Breathing chemical fumes in poorly ventilated laundry rooms or garages turns routine chores dangerous. Most folks shrug off mild symptoms, chalking them up to tiredness or a cold, until things escalate.
Short-term symptoms pass, but years of exposure add up. Repeated inhalation or skin contact with certain substances has been linked to chronic respiratory diseases, hormone disruption, or even cancer. Benzene, once present in many industrial and consumer products, is recognized by the World Health Organization as a carcinogen. The EPA continues to tighten rules on permissible exposure, but old habits die hard in workplaces resistant to change.
Kids face higher risks. Even tiny doses can cause issues in developing bodies. Leaded paints, now banned, remind us how legacy compounds stick around and keep harming new generations. Pesticides contribute to this. The links between some herbicides and neurological conditions are no longer just speculative; studies in peer-reviewed journals such as Environmental Health Perspectives highlight measurable dangers.
Experience has taught me that reading the fine print beats dealing with side effects later. Leaping into action, I make it a habit not only to wear gloves but to keep a detailed account of chemical names and concentration listed on packaging. Government agencies like the National Institute for Occupational Safety and Health (NIOSH) publish valuable, understandable data about toxicity and safety thresholds. I bookmark those pages for quick reference.
Replacing high-risk compounds with safer alternatives often makes a big difference. Simple swaps, like vinegar and water for cleaning instead of commercial products containing ammonia or bleach, help protect lungs and skin. At work, asking for updated safety data sheets before handling unfamiliar substances cuts down on unpleasant surprises. Clear labeling and ongoing training can lower accidents on the job. At home, locking up supplies away from kids and pets is a small step with big payoffs.
Knowing the risks tied to chemical compounds hands power back to consumers and workers. Backed by facts—drawn from science and lived experience—we prevent, prepare, and respond without panic. One less rash, one less hospital trip, all by taking these hazards seriously and demanding stronger transparency from manufacturers.
| Names | |
| Preferred IUPAC name | 3-[3-(Biphenyl-4-yl)-3,4-dihydro-1H-naphthalen-1-yl]-4-hydroxy-2H-chromen-2-one |
| Other names |
Brodifacoum Brodificoum BFC Talon Volid Havoc |
| Pronunciation | /ˈθriː ˌbaɪˈfiːnɪl ˈfɔr aɪl ˌwʌn ˌtuː ˌθriː ˌfɔr ˈtɛtrəˌhaɪdrə ˈwʌn ˈnæfθɪl ˈfɔr ˈhaɪdrɒksiˈkuːmərɪn/ |
| Identifiers | |
| CAS Number | 128912-25-6 |
| 3D model (JSmol) | `3D Model (JSmol) String:` `CN1CCc2c(C1)c3ccc(cc3c4ccc(cc4)cc5ccccc5)c6ccc(oc6)C(=O)O` |
| Beilstein Reference | 3210713 |
| ChEBI | CHEBI:3500 |
| ChEMBL | CHEMBL218011 |
| ChemSpider | 8568905 |
| DrugBank | DB07995 |
| ECHA InfoCard | 03e1e03d-c364-4c7c-a676-074f3d2eaf7e |
| EC Number | NA |
| Gmelin Reference | 1151515 |
| KEGG | C18807 |
| MeSH | D053220 |
| PubChem CID | 69344013 |
| RTECS number | DJ1196000 |
| UNII | 66P88F7D8N |
| UN number | UN3276 |
| CompTox Dashboard (EPA) | DTXSID8054083 |
| Properties | |
| Chemical formula | C31H23O3 |
| Molar mass | 540.65 g/mol |
| Appearance | White solid |
| Odor | Odorless |
| Density | 1.26 g/cm³ |
| Solubility in water | insoluble |
| log P | 5.9 |
| Vapor pressure | Vapor pressure: 2.65E-16 mmHg at 25°C |
| Acidity (pKa) | 8.7 |
| Basicity (pKb) | 5.62 |
| Refractive index (nD) | 1.648 |
| Viscosity | 759.6 cP |
| Dipole moment | 4.94 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 795.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -34.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | Std enthalpy of combustion (ΔcH⦵298) of 3-[(3-Biphenyl-4-Yl)-1,2,3,4-Tetrahydro-1-Naphthyl]-4-Hydroxycoumarin is -12204 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | B01AA10 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P261, P264, P272, P273, P280, P302+P352, P305+P351+P338, P362+P364, P337+P313, P501 |
| NFPA 704 (fire diamond) | 1-2-0-🛇 |
| Flash point | >150°C |
| LD50 (median dose) | LD50 (median dose): **520 mg/kg (oral, mouse)** |
| NIOSH | WQ8360000 |
| PEL (Permissible) | Not Established |
| REL (Recommended) | REL: 10 mg/m³ |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Warfarin Phenprocoumon Acenocoumarol Dicoumarol Brodifacoum Coumatetralyl Difenacoum |